The risk assessment tool could help health systems and researchers alike determine when patients face greater odds of post-PCI complications. 

New research published in Annals of Rheumatic Diseases and Hypertension examined the impact medications for different non-cardiovascular conditions can have on a patient's heart health.

According to data submitted to the FDA, the platform has been linked to an accuracy of 90%, sensitivity of 87.8% and specificity of 83%.

A new scientific statement from the American Heart Association examined the potential impact of many therapies, including fish oil supplements, lily of the valley and yoga.

Diagnostic catheters, ablation catheters and stents are just some of the solutions cardiologists are now struggling to obtain.

Medtronic presented the real-world data at the PCR London Valves 2022 conference. The company's Evolut FX TAVR system gained FDA approval back in August 2021. 

The new study, published in Circulation, represents a collaboration between specialists from a variety of facilities, including Cleveland Clinic and the University of Arizona. 

With the midterms in the rearview, the lameduck Congress is focused on a handful of healthcare priorities heading into 2023, including mental health and implementing recent Medicare price negotiations afforded in the Inflation Reduction Act.

An AI startup has been cleared to market a platform for precisely mapping prostate cancer with 3D visualization so the tumor can be treated without harm to healthy surrounding prostate tissue.